{"id":"https://openalex.org/W7213313641","doi":"https://doi.org/10.1002/iid3.70527","title":"Somatic Hypermutations Enhance Neutralization Breadth of IGHV3\u201053/3\u201066 Public Antibodies Against SARS\u2010CoV\u20102 Variants","display_name":"Somatic Hypermutations Enhance Neutralization Breadth of IGHV3\u201053/3\u201066 Public Antibodies Against SARS\u2010CoV\u20102 Variants","publication_year":2026,"publication_date":"2026-09-01","ids":{"openalex":"https://openalex.org/W7213313641","doi":"https://doi.org/10.1002/iid3.70527","pmid":"https://pubmed.ncbi.nlm.nih.gov/42747156","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13580150"},"language":"en","primary_location":{"id":"doi:10.1002/iid3.70527","doi":"https://doi.org/10.1002/iid3.70527","is_oa":true,"landing_page_url":"https://doi.org/10.1002/iid3.70527","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/iid3.70527","source":{"id":"https://openalex.org/S2764380340","display_name":"Immunity Inflammation and Disease","issn_l":"2050-4527","issn":["2050-4527"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunity, Inflammation and Disease","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/iid3.70527","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044801294","display_name":"Takeo Kuwata","orcid":"https://orcid.org/0000-0001-7793-6585","observed_orcids":["https://orcid.org/0000-0001-7793-6585"]},"institutions":[{"id":"https://openalex.org/I4210129349","display_name":"Kaketsuken (Japan)","ror":"https://ror.org/037x16a12","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210129349"]},{"id":"https://openalex.org/I4405285757","display_name":"Joint Research Center for Human Retrovirus Infection, Kumamoto University","ror":"https://ror.org/0059h2t89","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405285757","https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Takeo Kuwata","raw_affiliation_strings":["Collaborative Research Program With the Chemo\u2010Sero\u2010Therapeutic Research Institute for Anti\u2010Viral Agents and Hematological Diseases, Joint Research Center for Human Retrovirus Infection Kumamoto University Kumamoto Japan"],"raw_orcid":"https://orcid.org/0000-0001-7793-6585","affiliations":[{"raw_affiliation_string":"Collaborative Research Program With the Chemo\u2010Sero\u2010Therapeutic Research Institute for Anti\u2010Viral Agents and Hematological Diseases, Joint Research Center for Human Retrovirus Infection Kumamoto University Kumamoto Japan","institution_ids":["https://openalex.org/I4210129349","https://openalex.org/I4405285757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038505487","display_name":"Kyo Okazaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I96036126","display_name":"Kumamoto University","ror":"https://ror.org/02cgss904","country_code":"JP","type":"education","lineage":["https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kyo Okazaki","raw_affiliation_strings":["Department of Analytical and Biophysical Chemistry, Faculty of Medical and Pharmaceutical Sciences Kumamoto University Kumamoto Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Analytical and Biophysical Chemistry, Faculty of Medical and Pharmaceutical Sciences Kumamoto University Kumamoto Japan","institution_ids":["https://openalex.org/I96036126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083819119","display_name":"Hiroshi Morioka","orcid":"https://orcid.org/0000-0001-6931-8242","observed_orcids":["https://orcid.org/0000-0001-6931-8242"]},"institutions":[{"id":"https://openalex.org/I96036126","display_name":"Kumamoto University","ror":"https://ror.org/02cgss904","country_code":"JP","type":"education","lineage":["https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Morioka","raw_affiliation_strings":["Department of Analytical and Biophysical Chemistry, Faculty of Medical and Pharmaceutical Sciences Kumamoto University Kumamoto Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Analytical and Biophysical Chemistry, Faculty of Medical and Pharmaceutical Sciences Kumamoto University Kumamoto Japan","institution_ids":["https://openalex.org/I96036126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018361778","display_name":"Yu Kaku","orcid":"https://orcid.org/0009-0002-7666-8915","observed_orcids":["https://orcid.org/0009-0002-7666-8915"]},"institutions":[{"id":"https://openalex.org/I33858575","display_name":"Nagoya City University","ror":"https://ror.org/04wn7wc95","country_code":"JP","type":"education","lineage":["https://openalex.org/I33858575"]},{"id":"https://openalex.org/I4405284444","display_name":"Nagoya City University East Medical Center","ror":"https://ror.org/03jrv0f64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284444"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yu Kaku","raw_affiliation_strings":["Department of Clinical Infectious Diseases, Graduate School of Medical Sciences Nagoya City University Nagoya Japan","Nagoya City University East Medical Center Nagoya Japan"],"raw_orcid":"https://orcid.org/0009-0002-7666-8915","affiliations":[{"raw_affiliation_string":"Department of Clinical Infectious Diseases, Graduate School of Medical Sciences Nagoya City University Nagoya Japan","institution_ids":["https://openalex.org/I33858575"]},{"raw_affiliation_string":"Nagoya City University East Medical Center Nagoya Japan","institution_ids":["https://openalex.org/I4405284444"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046411023","display_name":"Mikiko Shimizu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129349","display_name":"Kaketsuken (Japan)","ror":"https://ror.org/037x16a12","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210129349"]},{"id":"https://openalex.org/I4405285757","display_name":"Joint Research Center for Human Retrovirus Infection, Kumamoto University","ror":"https://ror.org/0059h2t89","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405285757","https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mikiko Shimizu","raw_affiliation_strings":["Collaborative Research Program With the Chemo\u2010Sero\u2010Therapeutic Research Institute for Anti\u2010Viral Agents and Hematological Diseases, Joint Research Center for Human Retrovirus Infection Kumamoto University Kumamoto Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Collaborative Research Program With the Chemo\u2010Sero\u2010Therapeutic Research Institute for Anti\u2010Viral Agents and Hematological Diseases, Joint Research Center for Human Retrovirus Infection Kumamoto University Kumamoto Japan","institution_ids":["https://openalex.org/I4210129349","https://openalex.org/I4405285757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5151775354","display_name":"Yoshimi Maruyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129349","display_name":"Kaketsuken (Japan)","ror":"https://ror.org/037x16a12","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210129349"]},{"id":"https://openalex.org/I4405285757","display_name":"Joint Research Center for Human Retrovirus Infection, Kumamoto University","ror":"https://ror.org/0059h2t89","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405285757","https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshimi Maruyama","raw_affiliation_strings":["Collaborative Research Program With the Chemo\u2010Sero\u2010Therapeutic Research Institute for Anti\u2010Viral Agents and Hematological Diseases, Joint Research Center for Human Retrovirus Infection Kumamoto University Kumamoto Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Collaborative Research Program With the Chemo\u2010Sero\u2010Therapeutic Research Institute for Anti\u2010Viral Agents and Hematological Diseases, Joint Research Center for Human Retrovirus Infection Kumamoto University Kumamoto Japan","institution_ids":["https://openalex.org/I4210129349","https://openalex.org/I4405285757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061207655","display_name":"Ahmed K. Hamdy","orcid":"https://orcid.org/0000-0002-1830-9132","observed_orcids":["https://orcid.org/0000-0002-1830-9132"]},"institutions":[{"id":"https://openalex.org/I4210129349","display_name":"Kaketsuken (Japan)","ror":"https://ror.org/037x16a12","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210129349"]},{"id":"https://openalex.org/I4405285757","display_name":"Joint Research Center for Human Retrovirus Infection, Kumamoto University","ror":"https://ror.org/0059h2t89","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405285757","https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ahmed K. Hamdy","raw_affiliation_strings":["Collaborative Research Program With the Chemo\u2010Sero\u2010Therapeutic Research Institute for Anti\u2010Viral Agents and Hematological Diseases, Joint Research Center for Human Retrovirus Infection Kumamoto University Kumamoto Japan"],"raw_orcid":"https://orcid.org/0000-0002-1830-9132","affiliations":[{"raw_affiliation_string":"Collaborative Research Program With the Chemo\u2010Sero\u2010Therapeutic Research Institute for Anti\u2010Viral Agents and Hematological Diseases, Joint Research Center for Human Retrovirus Infection Kumamoto University Kumamoto Japan","institution_ids":["https://openalex.org/I4210129349","https://openalex.org/I4405285757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066652419","display_name":"Tateki Suzuki","orcid":"https://orcid.org/0000-0002-6946-3850","observed_orcids":["https://orcid.org/0000-0002-6946-3850"]},"institutions":[{"id":"https://openalex.org/I22299242","display_name":"Kyoto University","ror":"https://ror.org/02kpeqv85","country_code":"JP","type":"education","lineage":["https://openalex.org/I22299242"]},{"id":"https://openalex.org/I4405264018","display_name":"Institute for Life and Medical Sciences, Kyoto University","ror":"https://ror.org/00pqz0q24","country_code":"JP","type":"education","lineage":["https://openalex.org/I22299242","https://openalex.org/I4405264018"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tateki Suzuki","raw_affiliation_strings":["Laboratory of Medical Virology, Institute for Life and Medical Sciences Kyoto University Kyoto Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Medical Virology, Institute for Life and Medical Sciences Kyoto University Kyoto Japan","institution_ids":["https://openalex.org/I22299242","https://openalex.org/I4405264018"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077654395","display_name":"Takao Hashiguchi","orcid":"https://orcid.org/0000-0001-7578-7571","observed_orcids":["https://orcid.org/0000-0001-7578-7571"]},"institutions":[{"id":"https://openalex.org/I22299242","display_name":"Kyoto University","ror":"https://ror.org/02kpeqv85","country_code":"JP","type":"education","lineage":["https://openalex.org/I22299242"]},{"id":"https://openalex.org/I4405264018","display_name":"Institute for Life and Medical Sciences, Kyoto University","ror":"https://ror.org/00pqz0q24","country_code":"JP","type":"education","lineage":["https://openalex.org/I22299242","https://openalex.org/I4405264018"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takao Hashiguchi","raw_affiliation_strings":["Laboratory of Medical Virology, Institute for Life and Medical Sciences Kyoto University Kyoto Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Medical Virology, Institute for Life and Medical Sciences Kyoto University Kyoto Japan","institution_ids":["https://openalex.org/I22299242","https://openalex.org/I4405264018"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018175091","display_name":"Kei Sato","orcid":"https://orcid.org/0000-0003-4431-1380","observed_orcids":["https://orcid.org/0000-0003-4431-1380"]},"institutions":[{"id":"https://openalex.org/I4405286826","display_name":"Institute of Medical Science, The University of Tokyo","ror":"https://ror.org/0376e0j29","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405286826","https://openalex.org/I74801974"]},{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kei Sato","raw_affiliation_strings":["Department of Microbiology and Immunology, Division of Systems Virology, The Institute of Medical Science The University of Tokyo Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology and Immunology, Division of Systems Virology, The Institute of Medical Science The University of Tokyo Tokyo Japan","institution_ids":["https://openalex.org/I4405286826","https://openalex.org/I74801974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102795999","display_name":"Shuzo Matsushita","orcid":"https://orcid.org/0000-0002-9649-8821","observed_orcids":["https://orcid.org/0000-0002-9649-8821"]},"institutions":[{"id":"https://openalex.org/I4210129349","display_name":"Kaketsuken (Japan)","ror":"https://ror.org/037x16a12","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210129349"]},{"id":"https://openalex.org/I4405285757","display_name":"Joint Research Center for Human Retrovirus Infection, Kumamoto University","ror":"https://ror.org/0059h2t89","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405285757","https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shuzo Matsushita","raw_affiliation_strings":["Collaborative Research Program With the Chemo\u2010Sero\u2010Therapeutic Research Institute for Anti\u2010Viral Agents and Hematological Diseases, Joint Research Center for Human Retrovirus Infection Kumamoto University Kumamoto Japan"],"raw_orcid":"https://orcid.org/0000-0002-9649-8821","affiliations":[{"raw_affiliation_string":"Collaborative Research Program With the Chemo\u2010Sero\u2010Therapeutic Research Institute for Anti\u2010Viral Agents and Hematological Diseases, Joint Research Center for Human Retrovirus Infection Kumamoto University Kumamoto Japan","institution_ids":["https://openalex.org/I4210129349","https://openalex.org/I4405285757"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5044801294","https://openalex.org/A5102795999"],"corresponding_institution_ids":["https://openalex.org/I4210129349","https://openalex.org/I4405285757"],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":{"value":3300,"currency":"USD","value_usd":3300},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"9","first_page":"e70527","last_page":"e70527"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/somatic-hypermutation","display_name":"somatic hypermutation","score":0.9750000238418579},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.890999972820282},{"id":"https://openalex.org/keywords/omicron-variant","display_name":"Omicron variant","score":0.9760000109672546},{"id":"https://openalex.org/keywords/broadly-neutralizing-antibodies","display_name":"broadly neutralizing antibodies","score":0.8199999928474426},{"id":"https://openalex.org/keywords/antibody-maturation","display_name":"antibody maturation","score":0.7570000290870667},{"id":"https://openalex.org/keywords/ba-4-ba-5","display_name":"BA.4/BA.5","score":0.8489999771118164},{"id":"https://openalex.org/keywords/jn-1","display_name":"JN.1","score":0.9599999785423279},{"id":"https://openalex.org/keywords/neutralization-breadth","display_name":"neutralization breadth","score":0.6679999828338623}],"concepts":[{"id":"https://openalex.org/C14086860","wikidata":"https://www.wikidata.org/wiki/Q337120","display_name":"Neutralization","level":3,"score":0.9144999980926514},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7692999839782715},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6226999759674072},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.604200005531311},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5097000002861023},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5023000240325928},{"id":"https://openalex.org/C134305767","wikidata":"https://www.wikidata.org/wiki/Q725508","display_name":"Somatic cell","level":3,"score":0.4661000072956085},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.4277999997138977},{"id":"https://openalex.org/C2781377902","wikidata":"https://www.wikidata.org/wiki/Q21418769","display_name":"Affinity maturation","level":3,"score":0.3628000020980835},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3529999852180481},{"id":"https://openalex.org/C128526571","wikidata":"https://www.wikidata.org/wiki/Q619302","display_name":"Somatic hypermutation","level":4,"score":0.33230000734329224},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.326200008392334},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.32519999146461487},{"id":"https://openalex.org/C3018913218","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody response","level":3,"score":0.2937999963760376},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.287200003862381},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.2759999930858612},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.25279998779296875}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009500","descriptor_name":"Neutralization Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D027041","descriptor_name":"Somatic Hypermutation, Immunoglobulin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D064370","descriptor_name":"Spike Glycoprotein, Coronavirus","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1002/iid3.70527","doi":"https://doi.org/10.1002/iid3.70527","is_oa":true,"landing_page_url":"https://doi.org/10.1002/iid3.70527","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/iid3.70527","source":{"id":"https://openalex.org/S2764380340","display_name":"Immunity Inflammation and Disease","issn_l":"2050-4527","issn":["2050-4527"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunity, Inflammation and Disease","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13580150","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13580150/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13580150/pdf/IID3-14-e70527.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immun Inflamm Dis","raw_type":"Text"},{"id":"pmid:42747156","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42747156","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunity, inflammation and disease","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:c4ae05af36074ece91b77f59e14b73a6","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/c4ae05af36074ece91b77f59e14b73a6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Immunity, Inflammation and Disease, Vol 14, Iss 9, Pp n/a-n/a (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1002/iid3.70527","doi":"https://doi.org/10.1002/iid3.70527","is_oa":true,"landing_page_url":"https://doi.org/10.1002/iid3.70527","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/iid3.70527","source":{"id":"https://openalex.org/S2764380340","display_name":"Immunity Inflammation and Disease","issn_l":"2050-4527","issn":["2050-4527"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunity, Inflammation and Disease","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3076484041","display_name":"\u30d1\u30f3\u30c7\u30df\u30c3\u30af\u306e 5W1H \u3092\u7406\u89e3\u3059\u308b\u305f\u3081\u306e\u7814\u7a76","funder_award_id":"25jf0126002h0003","funder_id":"https://openalex.org/F4320311405","funder_display_name":"Japan Agency for Medical Research and Development"},{"id":"https://openalex.org/G3323909640","display_name":null,"funder_award_id":"JP223fa627009","funder_id":"https://openalex.org/F4320311405","funder_display_name":"Japan Agency for Medical Research and Development"},{"id":"https://openalex.org/G7064080594","display_name":"\u4e2d\u548c\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53\u3092\u7528\u3044\u305f\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306e\u6cbb\u7642\u6cd5\u306e\u958b\u767a","funder_award_id":"23ym0126048h0003","funder_id":"https://openalex.org/F4320311405","funder_display_name":"Japan Agency for Medical Research and Development"}],"funders":[{"id":"https://openalex.org/F4320311405","display_name":"Japan Agency for Medical Research and Development","ror":"https://ror.org/004rtk039"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7213313641.pdf","grobid_xml":"https://content.openalex.org/works/W7213313641.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W3049166744","https://openalex.org/W3174602360","https://openalex.org/W4389303638","https://openalex.org/W4394595977","https://openalex.org/W4403983225","https://openalex.org/W4411187501","https://openalex.org/W4417220061","https://openalex.org/W4417519244","https://openalex.org/W7117586099","https://openalex.org/W7168190407","https://openalex.org/W7170955441"],"related_works":["https://openalex.org/W4389303638","https://openalex.org/W4403983225","https://openalex.org/W4384825586","https://openalex.org/W7203728493","https://openalex.org/W4407902131","https://openalex.org/W3182696180","https://openalex.org/W7168190407","https://openalex.org/W4368375750","https://openalex.org/W4394595977","https://openalex.org/W7140325367"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Severe":[1],"acute":[2],"respiratory":[3],"syndrome":[4],"coronavirus":[5],"2":[6],"(SARS-CoV-2)":[7],"continuously":[8],"evolves":[9],"to":[10,140],"evade":[11],"antibodies":[12,22,52,64,94],"elicited":[13],"by":[14],"prior":[15],"infection":[16],"or":[17],"vaccination.":[18],"Most":[19],"IGHV3-53/3-66":[20,51,70,126],"public":[21,148],"potently":[23],"neutralize":[24],"the":[25,69,82,97,125,135,142],"prototype":[26],"strain,":[27],"but":[28],"show":[29,121],"limited":[30],"activity":[31,40],"against":[32,103],"recent":[33],"variants.":[34,105],"However,":[35],"some":[36],"acquire":[37],"broad":[38],"neutralizing":[39,50,57,93],"through":[41],"accumulation":[42],"of":[43,62,101,112,137,144],"somatic":[44],"hypermutations.":[45],"We":[46],"assessed":[47],"whether":[48],"non-broadly":[49],"could":[53],"mature":[54],"into":[55,108],"broadly":[56,92],"antibodies.":[58,84,149],"METHODS:":[59],"A":[60],"series":[61],"mutant":[63],"was":[65],"constructed":[66],"based":[67],"on":[68],"antibodies,":[71],"9-105":[72,102],"and":[73,76,99,116,132],"K4-66.":[74],"Neutralizing":[75],"binding":[77,100],"activities":[78],"were":[79],"compared":[80],"with":[81],"original":[83],"RESULTS:":[85],"Introducing":[86,106],"six":[87],"mutations":[88,123],"frequently":[89],"observed":[90],"in":[91],"markedly":[95],"improved":[96],"neutralization":[98,111],"Omicron":[104],"Y66F":[107],"K4-66":[109],"enhanced":[110],"variants":[113],"including":[114],"BA.4/5":[115],"JN.1.":[117],"CONCLUSION:":[118],"These":[119],"findings":[120],"that":[122],"within":[124],"gene":[127],"can":[128],"enhance":[129],"antibody":[130],"breadth":[131],"potency,":[133],"suggesting":[134],"potential":[136],"vaccine":[138],"strategies":[139],"promote":[141],"maturation":[143],"these":[145],"widely":[146],"prevalent":[147]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-09-16T00:00:00"}